C12N 2740/15034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2740/15034 (Use of virus or viral component as vaccine) appears on 217 US grants and 338 published applications in this corpus.
Search patents in C12N- Granted patents
- 217
- Published applications
- 338
- Assignees
- 159
- Inventors
- 484
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 7 | 0 |
| 1999 | 1 | 0 |
| 2000 | 4 | 0 |
| 2001 | 4 | 1 |
| 2002 | 2 | 6 |
| 2003 | 7 | 16 |
| 2004 | 2 | 17 |
| 2005 | 0 | 14 |
| 2006 | 7 | 13 |
| 2007 | 5 | 7 |
| 2008 | 6 | 11 |
| 2009 | 8 | 10 |
| 2010 | 6 | 20 |
| 2011 | 7 | 13 |
| 2012 | 6 | 17 |
| 2013 | 3 | 11 |
| 2014 | 13 | 20 |
| 2015 | 13 | 18 |
| 2016 | 12 | 18 |
| 2017 | 11 | 12 |
| 2018 | 14 | 19 |
| 2019 | 10 | 12 |
| 2020 | 13 | 16 |
| 2021 | 12 | 16 |
| 2022 | 10 | 13 |
| 2023 | 8 | 10 |
| 2024 | 8 | 11 |
| 2025 | 8 | 10 |
| 2026 | 4 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for membrane protein structure determination12 May 2026US 12,624,092 B2The Regents of the University of Michigan
- Persistent memory T-cell responses to cancer and infectious-disease antigens by manipulation of amino acid-catabolism pathways24 Mar 2026US 12,582,709 B2The Regents of the University of California
- IL-10 inhibition for vaccines and immunotherapy24 Feb 2026US 12,558,413 B2The Regents of the University of California
- Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host13 Jan 2026US 12,521,428 B2Institut Pasteur
- Vaccination using herpesvirus genomes in nucleic acid form14 Oct 2025US 12,440,554 B2The Regents of the University of California
- Stabilization of human immunodeficiency virus (hiv) envelopes11 Jun 2026US 2026/0158133 A1
- Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host23 Apr 2026US 2026/0108591 A1Institut Pasteur
- Compositions and methods for making and using stabilized enveloped viruses by spray-drying and lyophilization2 Apr 2026US 2026/0091106 A1The Regents of the University of Colorado, a body corporate
- Conjugate polypeptides and vaccines for inducing immune responses12 Mar 2026US 2026/0069678 A1The Regents of the University of California
- Composition for treating hiv infection22 Jan 2026US 2026/0021133 A1National Institutes of Biomedical Innovation, Health and Nutrition
Most cited
By later US patents
- Methods for treatment of cancer368US 8,906,682 B2The Trustees of the University of Pennsylvania · 2014
- Compositions for treatment of cancer277US 8,911,993 B2The Trustees of the University of Pennsylvania · 2014
- Methods for treatment of cancer216US 8,916,381 B1The Trustees of the University of Pennyslvania · 2014
- Compositions for treatment of cancer199US 8,975,071 B1The Trustees of the University of Pennsylvania · 2015
- Methods for treatment of cancer199US 9,101,584 B2The Trustees of the University of Pennsylvania · 2015